Fujirebio Diagnostics

Fujirebio Diagnostics is a leader in cancer biomarker assays and in vitro diagnostics. Their products support early detection and monitoring of disease, aiding clinicians in making informed treatment decisions.

All by Fujirebio Diagnostics

Fujirebio Diagnostics Files 510(K) with FDA for Lumipulse® G ?-Amyloid Ratio (1-42/1-40) in Vitro Diagnostic Test
| 2 min read
Page 1 of 1 - 1 Total Items

CURRENT ISSUE - November/December 2025

AI & Automation

Preparing Your Lab for the Next Stage

Lab Manager Nov/Dec 2025 Cover Image